Objective To evaluate the effectiveness and safety of medical sodium hyaluronate gels on the prevention of postoperative adhesion after abdominal and pelvic operation in the Department of general surgery, and discuss its clinical practical value. Methods Total 521 patients undergoing pelvic and abdominal operation were selected and randomly divided into experimental group(263cases)and control group(258cases).The sodium hyaluronate gels were used in the experimental group to coat over the operative area and adjacent parts, but not in the control group. After the surgery, the recorded data was analyzed statisticaly. Results In the experimental group: the mean time for passage of stools(19.8±1.7)h, the leucocyte count increased:8.0%(21cases),physical examination with the pain and discomfort:6.8%(18cases),post-operative adhesion:16cases included 3 cases of type Ⅰ and 13 cases of type Ⅱ.In the control group: the mean time for passage of stools(37.1±3.6)h, the leucocyte count increase:40.7%(105cases),physical examination with the pain and discomfort:24.0%(62cases),post-operative adhesion:94 cases include 39 cases of type Ⅰ and 55 cases of type Ⅱ.Conclusion The sodium hyaluronate gels may decrease the risk of postoperative adhesion formation, reduce the incidence of postoperative infection, pain, discomfort and other symptoms. It is worthy of clinical application and promotion.
Reference from Chinese Journal of General Practice
Writer: Gu Qiu-zhong, the First people's Hospital of Pinghu, Zhejiang, China.
-
singclean | 2017-08-14
2026 Global Dermal Filler Trend Outlook:As the global medical aesthetics market continues to evolve, consumer and clinician demands for dermal fillers are undergoing an unprecedented paradigm shift. From the early days of "blind filling and chasing volume" to today's focus on "anatomical refinement, natural facial dynamics, and ultimate comfort," the industry has officially entered the Hyaluronic Acid 4.0 Era. In this transformation driven by safety, comfort, longevity, and natural results, innovative Chinese brands like Singderm® are accelerating their breakthrough into the premium global aesthetics landscape, powered by proprietary technologies and rigorous international standards. -
singclean | 2017-08-14
Dual-Exhibition Global Layout! Singclean Medical to Showcase Premium Biomaterials and IVD Innovations at WHX Miami & WHX Bangkok 2026With the rapid advancement and technical iteration of the global healthcare industry, international presence has become the core engine for the sustainable growth of leading medical device enterprises. Hangzhou Singclean Medical Products Co., Ltd. (Singclean Medical), a globally recognized leader in medical biomaterials and In Vitro Diagnostics (IVD), has announced its upcoming participation in two world-class healthcare exhibitions from June to July 2026: WHX Miami (World Health Expo Miami 2026) in the United States and WHX Bangkok (World Health Expo Bangkok 2026) in Thailand. Singclean Medical will seize these opportunities to demonstrate its latest achievements under the dual-wheel drive of "Medical Biomaterials" and "In Vitro Diagnostics," cordially inviting global partners to explore new horizons in medical healthcare. -
singclean | 2017-08-14
Singclean Medical Shines at Mevos 2026 with Two New Singfiller Products, Ushering in a New Decade of Precision Filling